Riskpilot← Back to searchSign inGet full accessTermino C 13624 AB
ABDissolvedOrg 5567478671Manufacture of pharmaceutical preparations · NACE 2120Est. 20080 employees
Revenue 2024
SEK 0
EBITDA margin
—
-148% vs 2023
Equity ratio
95.8%
Financial strength
Net profit 2024
SEK -443K
-534% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -283K | -148% |
| Net profit | SEK -443K | -534% |
| Total assets | SEK 355K | -31% |
| Equity | SEK 340K | -33% |
| Employees | 0 | — |
Legal name
Termino C 13624 AB
Org number
5567478671
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
2 januari 2008
Share capital
SEK 1 200 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget skall bedriva förvaltning av värdepapper samt därmed jämförlig verksamhet.
Address
Phone
+46709147196
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −165 | −188 | 579 | 593 | −283 |
| Depreciation & amort. | −477 | −477 | −448 | −470 | −160 |
| EBIT | −642 | −665 | 131 | 123 | −443 |
| Net financials | −20 | −110 | −56 | −21 | — |
| Profit before tax | −662 | −775 | 76 | 102 | −443 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −662 | −775 | 76 | 102 | −443 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 840 | 1 412 | 932 | 517 | 355 |
| Equity | 369 | −170 | 81 | 508 | 340 |
| Long-term debt | 1 133 | 1 573 | 841 | 0 | 0 |
| Short-term debt | 338 | 9 | 10 | 9 | 15 |
| Total debt | 1 471 | 1 582 | 851 | 9 | 15 |
EBITDA margin
-28300000.0%
This company
15.8%
Market median
-179114024% vs market
20202024
Equity ratio
95.8%
This company
38.2%
Market median
+151% vs market
20202024
Return on equity
-130.3%
This company
18.4%
Market median
-808% vs market
20202024
Net profit margin
-44300000.0%
This company
8.1%
Market median
-546913680% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2025 | |
| Former (4) | ||
| Chairman | 2021 – 2024 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2021 – 2024 | |
| Deputy Board Member | 2021 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Termino C 13624 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Björn Jan Anders Johansson Enejder | Chairman | 0 companies |
| Anders Jakob Lindquist | Deputy Board Member | 0 companies |
| Torbjörn Nordberg | Board of Directors | 0 companies |
| Karin Ida Emelie Gustafsson | Board of Directors | 0 companies |
| Jens Christian Mogensen | Board of Directors | 0 companies |
| Ingmar Henry Qvist | Deputy Board Member | 0 companies |